GB1199951A — Modified Dextran and Derivatives Thereof
Assigned to Fisons Pharmaceuticals Ltd · Expires 1970-07-22 · 56y expired
What this patent protects
1,199,951. Dextran preparations. FISONS PHARMACEUTICALS Ltd. 29 April, 1968 [13 May, 1967], No. 22278/67. Heading A5B. [Also in Division C3U] Iron deficiency diseases are treated by injection of a solution of a modified dextran, or salt or lactone thereof or a complex of any ther…
USPTO Abstract
1,199,951. Dextran preparations. FISONS PHARMACEUTICALS Ltd. 29 April, 1968 [13 May, 1967], No. 22278/67. Heading A5B. [Also in Division C3U] Iron deficiency diseases are treated by injection of a solution of a modified dextran, or salt or lactone thereof or a complex of any thereof and which contains at least one terminal group of formula:-
Drugs covered by this patent
- Injectafer (FERRIC CARBOXYMALTOSE) · Am Regent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.